Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on SAM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106399418B reveals a transaminase route for moxifloxacin intermediates. Achieve >99% ee and reduced costs with our scalable biocatalytic manufacturing solutions.
Novel fermentation hydrolysis method for Aminoglucose Hydrochloride. High purity, reduced cost, scalable supply chain solution for pharmaceutical manufacturers.
Patent CN104610385B details advanced purification for glucosamine HCl. Enhances yield and supply chain reliability for pharmaceutical and food additive manufacturers.
Novel lacosamide synthesis avoiding toxic reagents. High yield, scalable process for reliable API intermediate supply chain partners.
Patent CN109293569B reveals solvent-free transamination using DMF. Achieve high-purity pharmaceutical intermediates with significant cost reduction and simplified supply chains.
Patent CN109293569A enables solvent-free formamide synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115466756A discloses novel immobilized transaminases for sitagliptin production. Achieve high conversion, stability, and cost reduction in pharmaceutical manufacturing.
Patent CN117467733B reveals immobilized transaminase process for Sitagliptin. Achieve high optical purity and cost reduction in API manufacturing with scalable biocatalysis.
Patent CN109576238A reveals efficient transaminase route for chiral beta-amino alcohols. Enables cost reduction and high-purity supply for pharmaceutical intermediates manufacturing.
Patent CN104672114A details a green synthesis route for Furosemide intermediates offering high purity and reduced environmental impact for reliable supply chains.
Patent CN119698468A details engineered transaminases for niraparib synthesis, offering high stereoselectivity and scalable biocatalytic solutions for pharmaceutical supply chains.
Patent CN115975969B reveals advanced transaminase mutants for Sitagliptin. Achieve high conversion and stereoselectivity for reliable pharmaceutical intermediate supply chains.
Patent CN106801043B reveals high-efficiency enzymatic synthesis for Sitagliptin intermediates, offering superior purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN113563301A reveals a novel three-step route for high-purity sesamol. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN106995807B reveals high-activity transaminase for Sitagliptin. Enables cost reduction in pharmaceutical intermediates manufacturing with superior enantioselectivity.
Patent CN102838639A reveals a copper-catalyzed route for N-aryl-D-glucosamine. This method offers significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN115583916B reveals a mild bisamide synthesis. Discover cost reduction in agrochemical manufacturing and high-purity supply chain solutions.
Patent CN112142699A reveals a green choline chloride eutectic solvent method for 3-acetamido-5-acetylfuran, offering cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN112553285B reveals a novel omega-transaminase method for L-glufosinate-ammonium. Achieve high purity and cost reduction in agrochemical manufacturing with scalable biocatalysis.
Patent CN116064449A discloses stable transaminase mutants for bulky chiral amines. Enables green synthesis, cost reduction, and reliable supply for pharmaceutical intermediates.